Health ❯ Healthcare ❯ Medical Research ❯ Clinical Trials

Breast Cancer Treatment

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

The latest EMBER-3 readout points to meaningful delays before chemotherapy for patients progressing after aromatase inhibitors.

Global Trial Finds Many Post-Mastectomy Patients Can Skip Chest-Wall Radiotherapy

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer